In the modified 8th AJCC/UICC classification, p16 was recommended as an HPV surrogate marker in OPSCC if there was diffuse (≥75%) expression and at least moderate (+2/3) staining intensity in the tumor.37 Here, CDKN2A is linked to neoplasm.